CVS CORP (CVS) is a publicly traded company in the Unknown sector. Across all available filings, 58 corporate insiders have executed 1020 transactions totaling $625.1M, demonstrating a bearish sentiment with -$612.4M in net insider flow. The most recent transaction on Jan 1, 2026 involved a transaction of 247 shares valued at $19.8K.
No significant insider buying has been recorded for CVS in the recent period.
No significant insider selling has been recorded for CVS in the recent period.
Based on recent SEC filings, insider sentiment for CVS is bearish with an Insider Alignment Score of 1/100 and a net flow of -$612.4M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at CVS CORP (CVS) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 58 insiders are actively trading CVS stock, having executed 1020 transactions in the past 90 days. The most active insider is Larry J. Merlo (Executive), who has made 63 transactions totaling $300.8M.
Get notified when executives and directors at CVS file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jan 1, 2026 | S. Shah Prem | EVP and Group President | Payment | 247 | $80.13 | $19.8K | |
| Dec 1, 2025 | David Clark James | Executive | Payment | 220 | $79.10 | $17.4K | |
| Nov 30, 2025 | B. Capozzi Heidi | Executive | Payment | 9,470 | $80.36 | $761.0K | Large |
| Nov 30, 2025 | N. Farah Roger | Executive | Payment | 9,748 | $80.36 | $783.3K | Large |
| Nov 30, 2025 | Mandadi Tilak | Executive | Payment | 6,575 | $80.36 | $528.4K | Large |
| Nov 20, 2025 | Aguirre Fernando | Executive | Award | 1,800 | $76.04 | $136.9K | |
| Nov 20, 2025 | R. Balser Jeffrey | Executive | Award | 1,775 | $76.04 | $135.0K | |
| Nov 20, 2025 | David Brown C. II | Executive | Award | 1,775 | $76.04 | $135.0K | |
| Nov 20, 2025 | A. Finucane Anne | Executive | Award | 591 | $76.04 | $44.9K | |
| Nov 20, 2025 | Scott Kirby J. | Executive | Award | 1,652 | $76.04 | $125.6K | |
| Nov 20, 2025 | Norwalk Leslie V | Executive | Award | 1,652 | $76.04 | $125.6K | |
| Nov 20, 2025 | P. Sansone Guy | Executive | Award | 1,652 | $76.04 | $125.6K | |
| Nov 20, 2025 | H. Shulman Douglas | Executive | Award | 1,652 | $76.04 | $125.6K | |
| Aug 31, 2025 | Mandadi Tilak | Executive | Payment | 12,834 | $73.15 | $938.8K | Large |
| Aug 31, 2025 | S. Shah Prem | Executive | Payment | 6,995 | $73.15 | $511.7K | Large |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 184 | $618.8M | 43.4% |
Exercise(M) | 145 | $335.2M | 23.5% |
Award(A) | 396 | $205.0M | 14.4% |
Payment(F) | 245 | $181.4M | 12.7% |
Other(J) | 13 | $70.5M | 4.9% |
Gift(G) | 17 | $8.7M | 0.6% |
Purchase(P) | 20 | $6.4M | 0.4% |
Insider selling pressure at CVS CORP has increased, with 58 insiders executing 1020 transactions across all time. Total sales of $618.8M significantly outpace purchases of $6.4M, resulting in a net outflow of $612.4M. This selling activity appears largely discretionary, which may warrant closer attention from investors.